therapeutic drug monitoring Flashcards
what is TDM
measure [drug] and [metabolites] to investigate the dosing to specific patients
when to perform TDM (4 reasons)
- low/narrow therapeutic range
- low patient compliance with drugs
- symptoms and toxicity of drug is hard to distinguish
- has pharmacokinetic variability
what pharmocokinetic variability can be measured by TDM
- inter-individual
- non-linear order drug kinetics
- drug-drug interactions
- physiological conditions (e.g. pregnancy) or underlying diseases
specimens for TDM
- serum/plasma
- EDTA-whole blood
- urine
- saliva/oral fluid
TDM measurements
- trough levels, prior to next dose to evaluate therapeutic effect
- peak levels at varying times to avoid toxic risks
methotrexate is monitored because
toxicity is common in high dose therapy
immune suppression, renal failure, myelosuppression, liver toxicity, neurological toxicity, GI toxicity, death
digoxin (heart failure drug) monitored because
low therapeutic index
GI distress, confusion, visual impairment, hyperkalemia, cardiac toxicity
phenytoin (anticonvulsant) monitored for
non-linear kinetics and inter-individual ability
ataxia, tremor, lethargy, seizure exacerbation, neuropsychiatric changes
lithium (bipolar disorder)
narrow therapeutic index, wide inter-individual variations
lethargy, weakness, slurred speech, ataxia, tremor, myoclonic jerks
aspirin monitored for
likely to overdose
nausea, vomiting, increased respiratory rate (alkalosis)
respiratory acidosis
- increased CO2
- unable to remove via respiration
metabolic acidosis
- increased acid
- kidney unable to clear
- underlying: diabetes, lactic acidosis, aspirin toxicity, dehydration
respiratory alkalosis
- decreased CO2
- hyperventillation, lack O2, high alttitude, aspirin poisoning